MGTX: meiragtx.com Company Sales Revenue

meiragtx.com - graphic logo of issuer MGTX

Costly cryogenic delivery of biomaterials complicates the supply chains of MeiraGTx Holdings plc (MGTX). The company's sales trend reflects current dynamics, where the indicator remains around 0.40. However, strict FDA oversight and patent barriers are hindering expansion. The situation is further complicated by a liquidity shortage, as massive clinical trial expenditures temporarily exceed the business's operating revenues.

MeiraGTx (MGTX) - Company Revenue from 07/04/2022 to 11/18/2026

Comprehensive metric breakdowns and analytics for MeiraGTx Holdings plc (MGTX)

- current price and projected stock value:
Summary company analysis:MeiraGTx Holdings plc
Brand item of MeiraGTx Corp

MeiraGTx Holdings plc (MGTX) is implementing a robotic GMP platform for automated vector synthesis to minimize human error. An analysis of corporate sales allows for an assessment of the commercial efficiency of this technological transformation. The indicator tracks daily revenue inflows, revealing the actual resilience of demand during periods of market volatility. Such granularity eliminates the misinterpretation of average values, demonstrating the actual liquidity of the business. The trend in inflows confirms the financial reliability and investment attractiveness of the capital.

Analysis of competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales